A personalized vaccine for melanoma cut the risk of cancer returning after five years
An experimental vaccine from Moderna shows promise in keeping deadly skin cancer from returning for years, according to new clinical trial results. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. The research, presented Monday at the American Society of Clinical Oncology’s annual meeting, found that a personalized mRNA … Read more